Tiziana Life Sciences PLC (LON:TILS – Get Rating)’s share price crossed above its 50-day moving average during trading on Thursday . The stock has a 50-day moving average of GBX 58.50 ($0.73) and traded as high as GBX 59 ($0.73). Tiziana Life Sciences shares last traded at GBX 58.50 ($0.73), with a volume of 297,127 shares traded.
Tiziana Life Sciences Trading Up 8.3 %
The firm has a market capitalization of £113.85 million and a PE ratio of -3.59. The firm’s fifty day moving average is GBX 58.50 and its two-hundred day moving average is GBX 58.50. The company has a debt-to-equity ratio of 2.36, a current ratio of 6.54 and a quick ratio of 6.41.
About Tiziana Life Sciences
Tiziana Life Sciences Plc, a clinical stage biotechnology company, focuses on the discovery and development of molecules and related diagnostics to treat diseases in oncology and immunology in the United Kingdom. Its product pipeline includes Foralumab (TZLS-401), a human anti-CD3 monclonal antibody for the treatment of autoimmune and inflammatory diseases, such as GvHD, ulcerative colitis, Crohn's disease, multiple sclerosis, type-1 diabetes, inflammatory bowel diseases, psoriasis, and rheumatoid arthritis; and Milciclib (TZLS-201), which is an orally bioavailable, small molecule inhibitor of cyclin-dependent kinases and Src family kinases for the treatment of hepatocellular carcinoma.
- Ralph Lauren’s Styled Dividend Is Still In Season
- Dollar Tree Falls As Theft Cuts Into Bottom Line
- Best Buy’s Comeback Is Still At Play, Earnings Call For Patience
- e.l.f. Beauty Has Giant Quarter, Shares Hit New High
- If You Can Only Pick One Stock For The Rest Of 2023, Pick Nvidia
Receive News & Ratings for Tiziana Life Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tiziana Life Sciences and related companies with MarketBeat.com's FREE daily email newsletter.